Exploration of drug science最新文献

筛选

英文中文

Recent exploration of γ-AApeptide based antimicrobial peptide mimics as potential therapeutics towards drug-resistant bacteria. 基于γ- aapep肽的抗菌肽模拟物作为耐药细菌潜在治疗手段的研究进展。

Exploration of drug science Pub Date : 2025-01-01 Epub Date: 2025-02-19 DOI: 10.37349/eds.2025.100888

Jarais Fontaine, Jianfeng Cai

引用次数: 0

Lipopeptide adjuvants for antibiotics and vaccines: the future step in the fight against multidrug-resistant and extensively drug-resistant pathogens. 用于抗生素和疫苗的脂肽佐剂：对抗多重耐药和广泛耐药病原体的未来步骤。

Exploration of drug science Pub Date : 2024-01-01 Epub Date: 2024-04-29 DOI: 10.37349/eds.2024.00043

Chloé O Sebilleau, Steven J Sucheck

{"title":"Lipopeptide adjuvants for antibiotics and vaccines: the future step in the fight against multidrug-resistant and extensively drug-resistant pathogens.","authors":"Chloé O Sebilleau, Steven J Sucheck","doi":"10.37349/eds.2024.00043","DOIUrl":"10.37349/eds.2024.00043","url":null,"abstract":"<p><p>With the surge of antibiotic resistance in bacteria, the need for a larger arsenal of effective antibiotics and vaccines has drastically increased in the past decades. Antibiotics like vaccines can benefit from significant potentiation when used in combination with adjuvants. Antibiotic adjuvants can allow for gram-positive bacteria (GPB) specific treatments to be used against gram-negative bacteria (GNB) infections, with minimal antimicrobial resistance (AMR). In the case of vaccines, they allow for modulation and increase of the immune response. Lipopeptides are molecules of choice because of their ability to activate specific cell surface receptors, penetrate the outer membrane of GNB, safety and ease of synthesis. This review explores the recent developments in lipopeptide adjuvants for antibiotics and vaccines, providing a roadmap on how to develop adjuvants to efficiently combat AMR. After a brief overview of bacterial resistance, lipopeptide adjuvants for antibiotics and vaccines are discussed, providing insights into stability, sources, and delivery methods. Findings discussed in this review could be applied to the development of safer, more effective adjuvants, that could expand the use or repurpose current antibiotics or improve vaccination results in future clinical trials.</p>","PeriodicalId":521004,"journal":{"name":"Exploration of drug science","volume":"2 ","pages":"203-233"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12366752/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144987174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0